Serotonin syndrome is caused by drug induced excess of intrasynaptic 5-hydroxytryptamine.
The clinical manifestations are mediated by the action of 5-hydroxytryptamine on various …

Serotonin syndrome (SS) is an important drug-related complication of psychopharmacologic
therapy for major depression, bipolar affective disorder, obsessive-compulsive disorder …

The selective pharmacology of the selective serotonin reuptake inhibitors (SSRIs) results in
a lower potential for pharmacodynamic drug interactions relative to other antidepressants …

This review focuses on the history of investigations into the behavioural reaction resulting
from excess stimulation of postsynaptic 5‐hydroxytryptamine receptors and the relative risk …

(Headache 2010; 50: 264‐272) The US Food and Drug Administration (FDA) have
suggested that fatal serotonin syndrome (SS) is possible with selective serotonin reuptake …

The serotonin1A receptor partial agonist, buspirone, also displays antagonist properties at
D2 receptors and is metabolized to the α2-adrenergic receptor antagonist, 1-(2-pyrimidinyl …

Thirty outpatients meeting DSM-III-R or DSM-IV criteria for major depression, single or
recurrent episode, and failing to respond to an adequate trial of an antidepressant (> 6 …

Synopsis Buspirone is an anxiolytic agent from the azapirone class of compounds. It differs
structurally and pharmacologically from the benzodiazepines. Although the exact anxiolytic …

Основные принципы СЛР были опубликованы в работах ВА Неговского, P. Safar и
других еще в 1954–1960 гг. Они обосновали эффективность закрытого массажа …

Abstract Neuroleptic Malignant Syndrome and Related Conditions is an important tool for
clinicians, outlining a framework for understanding, diagnosing, treating, and preventing …